Laboratories

Warfarin dose/response

This algorithm identifies patients who have a stable within-range INR (assuming a target INR of 2-3) over at least a three week period and correlates with their warfarin weekly dose.  It is used to identify pharmacogenetics behind warfarin stable dose.

Owner Phenotyping Groups: 
VESPA - Vanderbilt Electronic Systems for Pharmacogenomic Assessment
View Phenotyping Groups: 
VESPA - Vanderbilt Electronic Systems for Pharmacogenomic Assessment
Final

White Blood Cell Indices

Genetic variation that predicts white blood count (WBC) and it differential, a marker of the health of the immune system.

WBC is unique among the identified inflammatory predictors of chronic disease in that it has been routinely measured in healthy patients in an unbiased way for the duration of the electronic medical record data. 

Owner Phenotyping Groups: 
eMERGE GHC/University of Washington Group
View Phenotyping Groups: 
eMERGE Phenotype WG
Final

Pages